Safety and Tolerability of Relugolix in Combination with Abiraterone or Apalutamide for Treatment of Patients with Advanced Prostate Cancer: Data from a 52-Week Clinical Trial
瑞卢戈利联合阿比特龙或阿帕鲁胺治疗晚期前列腺癌患者的安全性和耐受性:一项为期 52 周的临床试验数据
期刊:Targeted Oncology
影响因子:4
doi:10.1007/s11523-025-01139-3
De La Cerda, Jose; Belkoff, Laurence; Courtney, Kevin D; Diamond, Elan; D'Olimpio, James; Dunshee, Curtis; Gervasi, Lawrence; Goodman, Michael; Mittal, Kriti; Morris, David; Sieber, Paul; Tutrone, Ronald; Ryan, Michael; Zhong, Yi; Ufer, Mike; Shore, Neal